BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 36111008)

  • 1. Bioinformatics analysis of BIRC5 in human cancers.
    Ye HB; Ma BJ; Meng GQ; Tao S; Wang Y; Chen Z; Zhao W; Ren BY; Ye Z
    Ann Transl Med; 2022 Aug; 10(16):888. PubMed ID: 36111008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The N6-Methylandenosine-Related Gene
    Jiang X; Shi Y; Chen X; Xu H; Huang X; Li L; Pu J
    Front Mol Biosci; 2022; 9():773662. PubMed ID: 35309512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ASPM Is a Prognostic Biomarker and Correlates With Immune Infiltration in Kidney Renal Clear Cell Carcinoma and Liver Hepatocellular Carcinoma.
    Deng T; Liu Y; Zhuang J; Tang Y; Huo Q
    Front Oncol; 2022; 12():632042. PubMed ID: 35515103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic analysis of the oncogenic role of FAM83D across cancers based on data mining.
    Geng Y; Liu J; Wang Z; Liu T; Peng X; Huang Y
    Cell Cycle; 2023 Apr; 22(8):1005-1019. PubMed ID: 36710419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CYP2J2 Is a Diagnostic and Prognostic Biomarker Associated with Immune Infiltration in Kidney Renal Clear Cell Carcinoma.
    Zou X; Mo Z
    Biomed Res Int; 2021; 2021():3771866. PubMed ID: 34258261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive analysis of prognostic value and immune infiltration of IAPs family in hepatocellular carcinoma.
    Yang X; Yu X; Nie H; Jiang W; Zhou J; Ou C; He X
    J Cancer; 2023; 14(15):2848-2866. PubMed ID: 37781078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
    Zhang X; Wang Y; A G; Qu C; Chen J
    Front Immunol; 2021; 12():721030. PubMed ID: 34531868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers.
    Wang N; Zhu L; Wang L; Shen Z; Huang X
    Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Pan-Cancer Analysis of the BIRC Gene Family and Its Association with Prognosis, Tumor Microenvironment, and Therapeutic Targets.
    Wu S; Zang Q; Xing Z; Li X; Leng J; Liu Y; Wang X; Yang J
    Crit Rev Eukaryot Gene Expr; 2021; 31(4):35-48. PubMed ID: 34587434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Early Diagnostic and Prognostic Value of BIRC5 in Clear-Cell Renal Cell Carcinoma Based on the Cancer Genome Atlas Data.
    Wang J; Chen M; Dang C; Zhang H; Wang X; Yin J; Jia R; Zhang Y
    Urol Int; 2022; 106(4):344-351. PubMed ID: 34265766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BIRC5 Modulates PD-L1 Expression and Immune Infiltration in Lung Adenocarcinoma.
    Ma T; Gu J; Wen H; Xu F; Ge D
    J Cancer; 2022; 13(10):3140-3150. PubMed ID: 36046648
    [No Abstract]   [Full Text] [Related]  

  • 12. Dual targeting of Polo-like kinase 1 and baculoviral inhibitor of apoptosis repeat-containing 5 in TP53-mutated hepatocellular carcinoma.
    Li Y; Zhao ZG; Luo Y; Cui H; Wang HY; Jia YF; Gao YT
    World J Gastroenterol; 2020 Aug; 26(32):4786-4801. PubMed ID: 32921957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LPAR2 correlated with different prognosis and immune cell infiltration in head and neck squamous cell carcinoma and kidney renal clear cell carcinoma.
    Sun K; Chen RX; Li JZ; Luo ZX
    Hereditas; 2022 Mar; 159(1):16. PubMed ID: 35241179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FIGNL1 Expression and its Prognostic Significance in Pan-cancer Analysis.
    Zhen Z; Li M; Zhong M; Ye L; Ma X
    Comb Chem High Throughput Screen; 2022; 25(13):2180-2190. PubMed ID: 35232348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analyzing the prognostic value of DKK1 expression in human cancers based on bioinformatics.
    Wei R; Rodrìguez RA; Mullor MDMR; Tan Z; Gui Y; Hu J; Zhu T; Huang X; Zhu Y; Xu J
    Ann Transl Med; 2020 Apr; 8(8):552. PubMed ID: 32411775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TLR3 serves as a novel diagnostic and prognostic biomarker and is closely correlated with immune microenvironment in three types of cancer.
    Zou X; Guo Y; Mo Z
    Front Genet; 2022; 13():905988. PubMed ID: 36419829
    [No Abstract]   [Full Text] [Related]  

  • 17. Prognostic value of baculoviral IAP repeat containing 5 expression as a new biomarker in lung adenocarcinoma: a meta-analysis.
    He D; Huang K; Liang Z
    Expert Rev Mol Diagn; 2021 Sep; 21(9):973-981. PubMed ID: 34176418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of prognostic significance of BIRC5 in breast cancer using integrative bioinformatics analysis.
    Dai JB; Zhu B; Lin WJ; Gao HY; Dai H; Zheng L; Shi WH; Chen WX
    Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32043523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the Expression and Prognostic Potential of a Novel Metabolic Regulator ANGPTL8/Betatrophin in Human Cancers.
    Xu F; Tian D; Shi X; Sun K; Chen Y
    Pathol Oncol Res; 2021; 27():1609914. PubMed ID: 34646087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Value of Long Noncoding RNA DLEU2 and Its Relationship with Immune Infiltration in Kidney Renal Clear Cell Carcinoma and Liver Hepatocellular Carcinoma.
    Fu S; Gong B; Wang S; Chen Q; Liu Y; Zhuang C; Li Z; Zhang Z; Ma M; Sun T
    Int J Gen Med; 2021; 14():8047-8064. PubMed ID: 34795513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.